A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2011
11/03/2011	US20110268754 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
11/03/2011	US20110268749 Treatment of cancer via targeting of il-13 receptor-alpha2
11/03/2011	US20110268748 NURR-1 Interacting Protein (NuIP)
11/03/2011	US20110268736 Method for treating congenital myopathy
11/03/2011	US20110268731 Methods of treating autoimmune disorders and/or inflammatory disorders
11/03/2011	US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011	US20110268722 Combination therapies with mitochondrial-targeted anti-tumor agents
11/03/2011	US20110268721 Therapy Regimens, Dosing Regimens And Stable Medicaments For The Treatment Of Pompe Disease
11/03/2011	US20110268720 Formulations of 5-fluorocytosine and uses thereof
11/03/2011	US20110268719 Annatto Extract Compositions, Including Geranyl Geraniols And Methods Of Use
11/03/2011	US20110268717 Herbal-Based Compositions for Alleviating Symptoms Associated with Autism
11/03/2011	US20110268713 Variants of Ancestral Uricases and Uses Thereof
11/03/2011	US20110268710 Methods of treating stroke using stem cell-like menstrual blood cells
11/03/2011	US20110268703 Probiotic strain and antimicrobial peptide derived therefrom
11/03/2011	US20110268700 Dosage regimens for hcv combination therapy
11/03/2011	US20110268699 Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles
11/03/2011	US20110268698 Methods for treating hepatitis c
11/03/2011	US20110268697 Hepatitis C Virus Inhibitors
11/03/2011	US20110268696 Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22
11/03/2011	US20110268695 Use of hmgb fragments as anti-inflammatory agents
11/03/2011	US20110268694 Methods for treating vascular leak syndrome
11/03/2011	US20110268690 Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
11/03/2011	US20110268680 Heat stable protein ingredients
11/03/2011	US20110268679 Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
11/03/2011	US20110268674 Polyamide-5 compounds in cosmetic preparations
11/03/2011	US20110268673 Skin Treatment
11/03/2011	US20110268670 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/03/2011	US20110268668 Process for nebulizing aqueous compositions containing highly concentrated insulin
11/03/2011	US20110268659 High shear application in drug delivery
11/03/2011	US20110268657 Compositions and methods for the treatment of tumor of hematopoietic origin
11/03/2011	US20110268654 Compositions and methods for delivering a substance to a biological target
11/03/2011	US20110265786 Inhalable Formulations For Treating Pulmonary Hypertension And Methods Of Using Same
11/03/2011	CA2797865A1 Methods, compositions, and kits for the treatment of matrix mineralization disorders
11/03/2011	CA2797858A1 Sox9 inhibitors
11/03/2011	CA2797431A1 Glucagon-like peptide-1 analogue and use thereof
11/03/2011	CA2795559A1 Crystalline peptide epoxyketone immunoproteasome inhibitor
11/03/2011	CA2793715A1 Peptide for improving in vivo stability of physiologically active substance or the like and physiologically active substance with improved in vivo stability
11/03/2011	CA2792965A1 Stable aqueous mia/cd-rap formulations
11/02/2011	EP2383342A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses
11/02/2011	EP2383336A1 Peptide capable of binding to immunoglobulin
11/02/2011	EP2383291A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/02/2011	EP2383290A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/02/2011	EP2383289A1 Receptor (SSTR2)-selective somatostatin antagonists
11/02/2011	EP2383287A1 Citrobacter rodentium secreted proteins
11/02/2011	EP2383286A1 Methods and compositions for treatment of retinal degenerative diseases
11/02/2011	EP2383282A1 Peptides for treatment of the human papillomavirus (HPV)-associated cancer and other epithelial tumors
11/02/2011	EP2383281A2 Prion-specific peptoid reagents
11/02/2011	EP2383278A1 Method to determine B cell mediated diseases
11/02/2011	EP2383013A1 Microneedle device
11/02/2011	EP2382991A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/02/2011	EP2382984A2 GRF analog compositions and their use
11/02/2011	EP2382983A1 Improved ApoE analogs and methods for their use
11/02/2011	EP2382982A2 Neural regeneration peptide and methods for their use in treatment of brain damage
11/02/2011	EP2382977A1 Therapeutic agents targeting the ncca-atp channel and methods of use thereof
11/02/2011	EP2382874A1 Amino acid supplementation for a healthy microbiota ecosystem
11/02/2011	EP2382316A1 A recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
11/02/2011	EP2382235A2 Novel caviidae allergens and uses thereof
11/02/2011	EP2382231A2 New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses
11/02/2011	EP2382230A2 Kxk-peptide compositions for cosmetic and dermo-pharmaceutic uses
11/02/2011	EP2382228A1 Compositions and methods of treating inflammatory and autoimmune diseases
11/02/2011	EP2382011A1 Compositions for the treatment of gluten intolerance and uses thereof
11/02/2011	EP2381957A2 Therapeutic modulation of vaginal epithelium boundary lubrication
11/02/2011	EP2381956A1 Treatment of soft tissue injury using hyaluronic acid and botulinum toxin
11/02/2011	EP2381955A1 Combination therapies using nap
11/02/2011	EP2381954A1 Methods and compositions based on shiga toxin type 2 protein
11/02/2011	EP2381953A1 Targeted antimicrobial moieties
11/02/2011	EP2381936A1 Pathways to generate hair cells
11/02/2011	EP2381934A2 Improving cognitive function
11/02/2011	EP2381928A2 Process for the preparation of a peptide powder form
11/02/2011	EP2381920A2 Methods and compositions for treating p.acnes
11/02/2011	EP2381788A2 Targeted cryptosporidium biocides
11/02/2011	EP2282766B1 Suture line administration technique using botulinum toxins
11/02/2011	EP2276504B1 Medicament and formulations thereof for use in reducing or preventing atherosclerosis
11/02/2011	EP2195013B1 Therapeutic use of a growth factor, metrnl
11/02/2011	EP2173371B1 Peptides derived from plasminogen activator inhibitor-1 and uses thereof
11/02/2011	EP2051730B1 Anti-h5n1 influenza activity of the antiviral protein cyanovirin
11/02/2011	EP2029231B1 Use of alpha-lactalbumin for regulation of glycemia
11/02/2011	EP1853250B1 Combinations and modes of administration of therapeutic agents and combination therapy
11/02/2011	EP1755659B1 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation
11/02/2011	EP1734971B1 Polymer-based sustained release device
11/02/2011	EP1684868B1 Treatment of hiv infections with hypochlorous acid-oxidised human blood plasma
11/02/2011	EP1631375B1 Injectable hydrogel microspheres from aqueous two-phase system
11/02/2011	EP1615952B1 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
11/02/2011	EP1508043B1 Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl
11/02/2011	EP1461449B1 System for monitoring bacterial tumor treatment
11/02/2011	EP1386165B1 Inflammatory markers for detection and prevention of diabetes mellitus
11/02/2011	EP1311290B1 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth
11/02/2011	EP1299522B1 Alteration of cell membrane
11/02/2011	EP1212359B1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein
11/02/2011	CN1972705B Use of sulglicotide for the treatement of mucositis
11/02/2011	CN1629185B Fusion proteins of mycobacterium tuberculosis antigens and their uses
11/02/2011	CN102232084A Neuregulin peptides and their use
11/02/2011	CN102232082A A nonapeptide with anti-tumour activity
11/02/2011	CN102231988A Pharmaceutical preparation comprising lipase of bacterial origin
11/02/2011	CN102231987A Neuregulin and cardiac stem cells
11/02/2011	CN102231981A Composition for sustained release delivery of proteins or peptides
11/02/2011	CN102231977A Delivery of dry formulations of octreotide
11/02/2011	CN102231976A Octreotide implant having a release agent
11/02/2011	CN102229939A Optimized high-activity human lysozyme gene as well as expression vectors and applications thereof
11/02/2011	CN102229934A Efficient production method and application of antimicrobial peptide PR-39 of pig small intestine in pichia pastoris

1 ... 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 ... 3163